Syverson Strege & Co’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-799
Closed -$23.9K 159
2023
Q1
$23.9K Sell
799
-34
-4% -$1.12K 0.01% 176
2022
Q4
$25.5K Buy
833
+1
+0.1% +$30 0.01% 162
2022
Q3
$21K Buy
832
+1
+0.1% +$33 0.01% 161
2022
Q2
$27K Buy
831
+1
+0.1% +$37 0.01% 166
2022
Q1
$26K Buy
830
+1
+0.1% +$31 0.03% 156
2021
Q4
$28K Buy
829
+101
+14% +$3.15K 0.02% 160
2021
Q3
$21K Hold
728
0.02% 189
2021
Q2
$25K Hold
728
0.02% 163
2021
Q1
$20K Buy
728
+1
+0.1% +$27 0.02% 164
2020
Q4
$18K Buy
+727
New +$17.3K 0.02% 159

Other funds holding CC

Syverson Strege & Co's CC Position: Q2 2023 in Review

Syverson Strege & Co sold out of Chemours (CC) in Q2 2023, closing a stake of 799 shares — an estimated $23.9K sold.

Syverson Strege & Co first reported a position in CC in Q4 2020 and held it in 10 quarters. The position peaked at $28K in Q4 2021. 476 funds tracked by Wall St. Rank hold CC as of Q2 2023.

  • Syverson Strege & Co reported no remaining Chemours position as of Q2 2023 after selling out during the quarter.
  • Syverson Strege & Co sold 799 Chemours shares in Q2 2023, an estimated $23.9K.
  • Syverson Strege & Co first reported a position in Chemours in Q4 2020 and held it in 10 quarters.
  • Syverson Strege & Co's Chemours position peaked at $28K in Q4 2021.
  • 476 funds tracked by Wall St. Rank held Chemours as of Q2 2023.

Based on Syverson Strege & Co's 13F filing for Q2 2023, filed 4 Aug 2023.